Exosens Stock Drops 6.63% and Falls Below a Key Technical Threshold
Exosens stock significantly declined this Thursday, April 9, dropping 6.63% to 62.65 euros by mid-morning, after closing at 67.10 euros the previous day. This downturn occurs amidst a general weakness in European markets, with the CAC 40 down 0.72% during the session at 8,204.70 points.
Today's drop in Exosens stock has caused the price to fall below its 20-day moving average, currently at 65.47 euros, whereas it had been trading above this level in previous sessions. This downward crossing is a sign of short-term vulnerability. The stock is now in the lower part of its Bollinger Bands, at 34% of the range between the lower bound at 56.45 euros and the upper bound at 74.49 euros, indicating selling pressure without yet reaching an oversold zone. Despite this correction, the stock remains above its 50-day moving average (60.93 euros), which could serve as a first stabilization level. The identified technical support is at 57.50 euros. Over a longer horizon, the performance remains strong with an increase of nearly 100% over one year and 13% over three months, supported by a price significantly higher than the 200-day moving average (48.50 euros).
Exosens Decline Part of a Broader Market Correction
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
Almost there! Check your inbox.
A confirmation email has been sent. Click the link to confirm your subscription.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Exosens' decline is part of a broader correction affecting technology and industrial stocks listed in Europe. During the session, ASML Holding is down 1.42% and Schneider Electric drops 1.09%, two stocks similar to the profile of the French optronics and detection specialist. The SBF 120, which includes Exosens, is down 0.68% at the same time. The market context remains marked by a high level of tension, with the VIX standing at 25.78 points, up 6.66% from its last available value. It is worth noting that the publication of Exosens' first quarter 2026 results is expected on April 27, an event that could provide new insights into the group's trajectory. The general assembly is scheduled for May 22.
Nous sommes fiers de présenter notre performance sur les neuf premiers mois de l’année 2025, qui témoignent d'une croissance soutenue du chiffre d'affaires et de la marge brute ajustée, portée par la forte dynamique du secteur de la Défense.
Marché de la Défense très dynamique, forte demande pour la vision nocturne et les systèmes pour drones/anti-drones, croissance soutenue en Europe avec contribution des États-Unis et de l’Asie-Pacifique. Lancement commercial réussi des tubes 5G (plus de 5 000 commandes avant lancement).
Risks mentioned
Cession de l’activité Amplification par Micro-ondes entraînant une perte comptable sans impact de trésorerie en 2025
Dépendance aux budgets de Défense et aux évolutions géopolitiques
Risque d'intégration des acquisitions récentes
Incertitudes de la demande dans les Sciences de la Vie (marché américain)
Opportunities identified
Croissance adressable liée à la vision nocturne et aux applications drones/anti-drones
Commercialisation des tubes 5G avec commandes significatives (>5 000 tubes)
Expansion des capacités de production (+40% d’ici 2027) soutenant le développement commercial
Effets de croissance externe (Noxant, NVLS, Phasics) élargissant le marché adressable
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.
